Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goldschmidt

Showing results (341-350 of 472) with videos related to

Pageof 48
Sort By:
Der Radiologe|January 1, 1997
[Positron emission tomography (PET) in diagnosis and therapy planning of malignant lymphoma]A Dimitrakopoulou-Strauss, L G Strauss, H Goldschmidt, et al.
Leukemia|January 22, 1998
A rationale for positive selection of peripheral blood stem cells in multiple myeloma: highly purified CD34+ cell fractions of leukapheresis products do not contain malignant cellsF W Cremer, K Kiel, C Sucker, et al.
British Journal of Cancer|July 23, 2013
Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitorsJ Moreaux, T Reme, W Leonard, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 9, 1998
Increased risk of catheter colonization and catheter-related infections in severe immunocompromized patients with multiple myeloma undergoing high-dose glucocorticoid treatmentH Goldschmidt, H J Salwender, U Hahn, et al.
European Journal of Nuclear Medicine|May 1, 1995
Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomasA Dimitrakopoulou-Strauss, L G Strauss, H Goldschmidt, et al.
Veterinary Pathology|December 28, 2012
Evaluation of clinical and histopathologic prognostic factors for survival in canine osteosarcoma of the extracranial flat and irregular bonesM A Kruse, E S Holmes, J A Balko, et al.
The American Journal of Pathology|November 5, 1997
Feline atopic dermatitis. A model for Langerhans cell participation in disease pathogenesisP J Roosje, D Whitaker-Menezes, M H Goldschmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myelomaK Neben, T Moehler, G Egerer, et al.
Frontiers in Oncology|January 11, 2020
Array Comparative Genomic Hybridization Analysis Reveals Significantly Enriched Pathways in Canine Oral MelanomaGinevra Brocca, Serena Ferraresso, Clarissa Zamboni, et al.
Immunotherapy|March 15, 2024
Outcomes for pembrolizumab stratified by pemetrexed maintenance post pembrolizumab-platinum-pemetrexed induction in metastatic non-small-cell lung cancerJerome H Goldschmidt, Srinivas Annavarapu, Divea Venkatasetty, et al.
Pageof 48

Showing results (341-350 of 472) with videos related to

Sort By:
Pageof 48
Der Radiologe|January 1, 1997
[Positron emission tomography (PET) in diagnosis and therapy planning of malignant lymphoma]A Dimitrakopoulou-Strauss, L G Strauss, H Goldschmidt, et al.
Leukemia|January 22, 1998
A rationale for positive selection of peripheral blood stem cells in multiple myeloma: highly purified CD34+ cell fractions of leukapheresis products do not contain malignant cellsF W Cremer, K Kiel, C Sucker, et al.
British Journal of Cancer|July 23, 2013
Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitorsJ Moreaux, T Reme, W Leonard, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 9, 1998
Increased risk of catheter colonization and catheter-related infections in severe immunocompromized patients with multiple myeloma undergoing high-dose glucocorticoid treatmentH Goldschmidt, H J Salwender, U Hahn, et al.
European Journal of Nuclear Medicine|May 1, 1995
Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomasA Dimitrakopoulou-Strauss, L G Strauss, H Goldschmidt, et al.
Veterinary Pathology|December 28, 2012
Evaluation of clinical and histopathologic prognostic factors for survival in canine osteosarcoma of the extracranial flat and irregular bonesM A Kruse, E S Holmes, J A Balko, et al.
The American Journal of Pathology|November 5, 1997
Feline atopic dermatitis. A model for Langerhans cell participation in disease pathogenesisP J Roosje, D Whitaker-Menezes, M H Goldschmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myelomaK Neben, T Moehler, G Egerer, et al.
Frontiers in Oncology|January 11, 2020
Array Comparative Genomic Hybridization Analysis Reveals Significantly Enriched Pathways in Canine Oral MelanomaGinevra Brocca, Serena Ferraresso, Clarissa Zamboni, et al.
Immunotherapy|March 15, 2024
Outcomes for pembrolizumab stratified by pemetrexed maintenance post pembrolizumab-platinum-pemetrexed induction in metastatic non-small-cell lung cancerJerome H Goldschmidt, Srinivas Annavarapu, Divea Venkatasetty, et al.
Pageof 48